Influence of formulation factors on the preparation of zein nanoparticles

AAPS PharmSciTech

Volumn 13, Issue 3, 2012, Pages 919-927

  Podaralla, Satheesh ^a,b   Perumal, Omathanu ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

drug delivery; particle size distribution; pH nanoprecipitation; protein polymers; zein; zeta potential

Indexed keywords

BUFFER; CITRIC ACID; ESCULETIN; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLOXAMER; SURFACTANT; ZEIN;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG FORMULATION; FREEZE DRYING; HYDROPHOBICITY; IONIC STRENGTH; NANOENCAPSULATION; PARTICLE SIZE; PH; PRIORITY JOURNAL; ZETA POTENTIAL;

CHEMISTRY, PHARMACEUTICAL; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; PARTICLE SIZE; ZEIN;

EID: 84866092922     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9816-1     Document Type: Article

References (41)

1. Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev. 2012;41:2545-61.
2. Wang G, Uldag H. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Exp Opin Drug Deliv. 2008;5:499-515.
3. Langer K, Balthasar S, Vogel V, Dinauer N, Briesen HV, Shubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 2003;257:169-80.
4. Kaul G, Amiji M. Tumor-targeted gene delivery using poly (ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm Res. 2005;22:951-61.
5. Reddy N, Yang Y. Potential of plant proteins for medical applications. Trend Biotechnol. 2011;29:490-8.
6. Satheesh P, Radhey K, Omathanu P. Protein based nanoparticulate drug delivery systems. In: Yashwant P, Deepak T, editors. Nanoparticulate drug delivery systems. II. Formulation and characterization. New York: Informa Healthcare; 2009. p. 69-91.
7. Yi YM, Yang TY, Pan WM. Preparation and distribution of 5-fluorouracil (125)I sodium alginate bovine serum albumin nanoparticles. World J Gastrol. 1999;5:57-60.
8. Cascone MG, Lazzeri L, Carmignani C, Zhu Z. Gelatin nanoparticles produced by a simple emulsion as delivery system for methotrexate. J Mater Sci Mater Med. 2002;13:523-6.
9. Wang SZ, Esen A. Primary structure of a proline rich zein and its cDNA. Plant Physiol. 1986;81:70-4.
10. Shukla R, Cheryan M. Zein: the industrial protein from corn. Ind Crops Prod. 2001;13:171-92.
11. Moros EE, Darnoko D, Cheryan M, Perkins EG, Jerrell J. Analysis of xanthophylls in corn by HPLC. J Agric Food Chem. 2002;50:5787-90.
12. Kale A, Zhu F, Cheryan M. Separation of high-value products from ethanol extracts of corn by chromatography. Ind Crop Prod. 2007;26:44-53.
13. Anonymous. Wheat gluten, corn gluten and zein film: affirmation of GRAS status. Fed Regist. 1985;50:8997-8999.
14. Gong SJ, Sun SX, Sun QS, Wang JY, Liu XM, Liu GY. Tablets based on compressed zein microspheres for sustained oral administration: design, pharmacokinetics and clinical study. J Biomater Appl. 2011;26:195-208.
15. Wang HJ, Lin ZX, Liu XM, Sheng SY, Wang JY. Heparin-loaded zein microsphere film and hemocompatibility. J Control Release. 2005;105:120-31.
16. Lai LF, Guo HX. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm. 2011;404:317-23.
17. Luo Y, Teng Z, Wang Q. Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem. 2012;60:836-43.
18. Patel A, Hu Y, Tiwari JK, Velikov KP. Synthesis and characterization of zein-curcumin colloidal particles. Soft Matter. 2010;6:6192-9.
19. Hurtando-Lopez P, Murdan S. Formulation and characterization of zein microspheres as drug delivery vehicles. J Drug Deliv Sci Tech. 2005;15:267-72.
20. Zhong Q, Jin M. Zein nanoparticles produced by liquid-liquid dispersion. Food Hydrocolloid. 2009;23:2380-7.
21. Zhong Q, Jin M, Xiao D, Tian H, Zhang W. Application of supercritical anti-solvent technologies for the synthesis of delivery systems of bioactive components. Food Biophys. 2008;3:186-90.
22. Satheesh P, Perumal O. Preparation of zein nanoparticles by pH controlled nanoprecipitation method. J Biomed Nanotechnol. 2010;6:312-7.
23. Guo Y, Liu Z, An H, Li M, Hu J. Nanostructure and properties of maize zein studied by atomic force microscopy. J Cereal Sci. 2005;41:277-81.
24. Demchak RJ, Dybas RA. Photostability of abamectin/zein microspheres. J Agric Food Chem. 1997;45:260-2.
25. Patel AR, Elisabeth CM, Bouwens M, Velikov KP. Sodium caseinate stabilized zein colloidal particles. J Agric Food Chem. 2010;58:12497-503.
26. Anhorn MG, Mahler HC, Langer K. Freeze drying of human serum albumin (HAS) nanoparticles with different excipients. Int J Pharm. 2008;363:162-9.
27. Magoshi J, Nakamura S, Murakami K. Structure and physical properties of seed proteins. I. Glass transition and crystallization of zein protein from corn. J Appl Polym Sci. 1992;45:2043-8.
28. Langer K, Anhorn MG, Steinhauser I, Dreis S, Celebi D, Schrickel N, et al. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int J Pharm. 2008;347:109-17.
29. Esen A. Separation of alcohol-soluble proteins (zeins) from maize into three fractions by differential solubility. Plant Physiol. 1986;80:623-7.
30. Irache JM, Bergougnoux L, Ezpeleta I, Gueguen J, Orecchioni AM. Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method. Int J Pharm. 1995;126:103-9.
31. Cabra V, Arreguin R, Vazquez-Duhalt R, Farres A. Effect of temperature and pH on the secondary structure and processes of oligomerization of 19 kDa alpha-zein. Biochim Biophys Acta. 2006;1764:1110-8.
32. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688-713.
33. Shalaev EY, Johnson-Elton TD, Chang L, Pikal MJ. Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying. Pharm Res. 2002;19:195-201.
34. Reddy N, Li Y, Yang Y. Alkali-catalyzed low temperatures wet cross linking of plant proteins using carboxylic acids. Biotechnol Prog. 2009;25:139-46.
35. Duclairoir C, Nakache E, Marchais H, Orecchioni AM. Formation of gliadin nanoparticles: influence of the solubility parameter of the protein solvent. Colloid Polym Sci. 1998;276:321-7.
36. Fairhurst D, Lee RW. The zeta potential and its use in pharmaceutical applicationspart 1: charged interfaces in polar and non-polar media and the concept of zeta potential. Drug Dev Deliv. 2011;11:60-4.
37. Schubert MA, Muller-Goymann CC. Characterization of surface modified solid lipid nanoparticles (SLN): influence of lecithin and non-ionic emulsifier. Eur J Pharm Biopharm. 2000;61:77-86.
38. Vanessa CFM, Philippe L, Huguette PA, Francis P, Gillian B. Poly(d,l-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. J Pharm Sci. 2000;89:614-26.
39. Dulieu C, Bazile D. Influence of lipid nanocapsules composition on their aptness to freeze-drying. Pharm Res. 2005;22:285-92.
40. Hong YZ, Xing T, Hong YL, Xiao LL. A lipid microsphere vehicle for vinorelbine: stability, and safety and pharmacokinetics. Int J Pharm. 2008;348:70-9.
41. Dulclairoir C, Nakache E. Polymer nanoparticle characterization in aqueous suspensions. Int J Polym Anal Charac. 2002;7:284-313.